Cancer treatments are nowadays quite effective in the first istance, but very often recurrent resistance phenomena arise with inauspicious prognostic outcomes. Study the adaptive cellular responses and the molecular mechanisms induced by short- and long-term treatments with anticancer drugs in different human cancer cells is useful in order to identify new potential molecular targets.